文献速递急腹症与外科感染围术期管理与 ERAS

急诊TEVAR优先治疗合并危重急性下肢缺血的复杂性B型主动脉夹层

[Efficacy and safety of emergency tevar for complicated type B aortic dissection with critical acute limb ischemia].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2026-01-01

本研究为回顾性病例系列,纳入20例coTBAD合并危重ALI(Rutherford Ⅱb~Ⅲ级)患者,均接受急诊TEVAR(≤24 h)。18例仅经TEVAR即实现下肢血运重建,院内死亡3例,随访示踝肱指数显著改善,累积生存率与免于截肢率在术后6个月至3年均为94.1%。

要点

  • 急诊TEVAR优先策略可有效逆转coTBAD合并危重ALI的下肢缺血
  • 90.0%(18/20)患者仅通过TEVAR即实现下肢血运重建
  • 院内死亡15.0%(3/20),2例与肠系膜上动脉缺血有关

核心结论

  • 对于合并危重急性下肢缺血的coTBAD患者,急诊TEVAR优先策略可有效逆转下肢缺血,使多数患者免于额外血运重建。
  • 中长期随访结果显示血流动力学改善良好。

研究设计与样本

  • 回顾性病例系列研究,纳入2016年10月至2020年2月中南大学湘雅二医院血管外科连续收治的20例coTBAD合并危重ALI(Rutherford Ⅱb~Ⅲ级)接受急诊TEVAR(≤24 h)治疗的患者。
  • 男性19例,女性1例,年龄(51.8±14.2)岁(范围:30~74岁)。
  • 主要观察指标为TEVAR术后下肢血运重建成功率,次要指标包括病死率及主要并发症发生率。

主要发现

  • TEVAR技术成功率为100%,18例(90.0%)仅通过TEVAR即实现下肢血运重建。
  • 院内死亡3例(15.0%),其中2例死因与合并肠系膜上动脉缺血有关,1例因患侧下肢缺血不可逆继发感染性休克及多器官功能衰竭死亡。
  • 患侧踝肱指数由术前0.28±0.19(范围:0~0.47)升至末次随访时0.93±0.12(范围:0.81~1.05)(t=14.89,P<0.01)。
  • Kaplan-Meier分析示术后6个月至3年累积生存率均为94.1%,术后1个月至3年累积免于截肢率均为94.1%。
  • 17例存活患者均获随访,随访时间80.0(31.5)个月(范围:6~105个月),15例肢体功能良好且未接受二次手术,1例因腰椎间盘突出症致中度间歇性跛行,1例截肢。

临床怎么用

  • 对coTBAD合并危重急性下肢缺血(Rutherford Ⅱb~Ⅲ级)患者,可考虑急诊TEVAR(≤24 h)作为优先策略以逆转下肢缺血。
  • TEVAR术后需关注合并肠系膜上动脉缺血等并发缺血情况,本研究中2例院内死亡与此相关。

局限性

  • 本研究为单中心回顾性病例系列,样本量20例,无对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the efficacy and safety of emergency thoracic endovascular aortic repair (TEVAR) as a first-line treatment for complicated type B aortic dissection (coTBAD) presenting with critical acute limb ischemia (ALI). Methods: A retrospective case series analysis was conducted on data from 20 consecutive patients with coTBAD and critical ALI (Rutherford class Ⅱb/Ⅲ) who underwent emergency TEVAR (≤24 hours from admission) at the Department of Vascular Surgery, Second Xiangya Hospital of Central South University between October 2016 and February 2020. There were 19 males and 1 female, with an age of (51.8±14.2) years (range: 30 to 74 years). Data on patient characteristics, perioperative outcomes, and follow-up were collected. The primary endpoint was the success rate of limb revascularization following TEVAR. Secondary endpoints included mortality and the incidence of major complications. Data were analyzed using descriptive statistics and paired sample t-tests. Survival and amputation-free survival were assessed using Kaplan-Meier analysis. Results: The procedure was technically successful in all cases. In-hospital mortality was 15.0% (3/20): two deaths were attributed to concomitant superior mesenteric artery ischemia, and one case resulted from irreversible lower limb ischemia precipitating septic shock and multiorgan failure. TEVAR alone successfully revascularized the lower extremity in 90.0% (18/20) of patients. The follow-up time was(M(IQR)) 80.0(31.5) months (range: 6 to 105 months), 15/17 of survivors maintained favorable limb function. No patient who achieved initial revascularization success required any additional vascular procedures during follow-up; one patient experienced claudication due to lumbar disc herniation, and one underwent amputation. The ankle-brachial index significantly improved from 0.28±0.19 (range: 0 to 0.47) preoperatively to 0.93±0.12 (range:0.81 to 1.05) at the final assessment (t=14.89, P<0.01). Kaplan-Meier analysis showed that the cumulative survival rate was 94.1% at 6 months postoperatively and remained stable through 3 years; similarly, the cumulative amputation-free rate was 94.1% at 1 month postoperatively and was sustained up to 3 years. Conclusions: For patients with coTBAD and critical ALI, an emergency TEVAR-first strategy effectively reverses limb ischemia and obviates the need for additional revascularization in most cases. Mid-to long-term follow-up confirms sustained hemodynamic improvement. 目的: 评估急诊胸主动脉腔内修复术(TEVAR)优先策略治疗合并危重急性下肢缺血的复杂性B型主动脉夹层(coTBAD)的临床效果。 方法: 本研究为回顾性病例系列研究。回顾性分析2016年10月至2020年2月中南大学湘雅二医院血管外科连续收治的因coTBAD合并危重急性下肢缺血(卢瑟福分级Ⅱb~Ⅲ级)接受急诊TEVAR(≤24 h)治疗的20例患者资料。男性19例,女性1例,年龄(51.8±14.2)岁(范围:30~74岁)。收集患者基线特征、围手术期及随访资料。主要观察指标为TEVAR术后下肢血运重建成功率,次要指标包括病死率及主要并发症发生率。手术前后数据比较采用配对样本t检验;采用Kaplan-Meier法绘制生存曲线并计算患者生存率和免于截肢率。 结果: 所有患者手术顺利完成,TEVAR技术成功率为100%。20例患者中,院内死亡3例,其中2例死因与合并肠系膜上动脉缺血有关,另1例因患侧下肢缺血不可逆,继发严重感染性休克及多器官功能衰竭死亡。18例患者仅通过TEVAR即实现下肢血运重建。17例存活患者均获得随访,随访时间[M(IQR)]为80.0(31.5)个月(范围:6~105个月),15例患者的存活患者肢体功能良好,且未接受二次手术治疗;1例患者因腰椎间盘突出症致中度间歇性跛行;1例截肢。患侧踝肱指数由术前的0.28±0.19(范围:0~0.47)升至末次随访时的0.93±0.12(范围:0.81~1.05)(t=14.89,P<0.01)。Kaplan-Meier分析结果显示,患者术后6个月至3年的累积生存率均为94.1%;术后1个月至3年的累积免于截肢率为94.1%。 结论: 对于合并危重急性下肢缺血的coTBAD患者,急诊TEVAR优先策略可有效逆转下肢缺血,使多数患者免于额外血运重建,中长期随访结果显示血流动力学改善良好。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang L, Li R, Xia DX, et al. [Efficacy and safety of emergency tevar for complicated type B aortic dissection with critical acute limb ischemia]. Zhonghua Wai Ke Za Zhi. 2026. PMID: 41667926. doi:10.3760/cma.j.cn112139-20251022-00493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。